原研机构 |
权益机构- |
最高研发阶段批准上市 |
最高研发阶段(中国)批准上市 |
特殊审评- |
分子式C21H28O5 |
InChIKeyOIGNJSKKLXVSLS-VWUMJDOOSA-N |
CAS号50-24-8 |
开始日期2025-05-01 |
申办/合作机构 |
开始日期2025-04-11 |
申办/合作机构 |
开始日期2025-04-07 |
申办/合作机构 |
适应症 | 国家/地区 | 公司 | 日期 |
---|---|---|---|
淋巴瘤 | 日本 | 2015-06-26 | |
粘膜皮肤淋巴结综合征 | 日本 | 2013-09-13 | |
粘膜皮肤淋巴结综合征 | 日本 | 2013-09-13 | |
多发性骨髓瘤 | 日本 | 2011-09-16 | |
多发性骨髓瘤 | 日本 | 2011-09-16 | |
湿疹 | 日本 | 1967-07-01 | |
自身免疫性疾病 | 中国 | - |
研究 | 分期 | 人群特征 | 评价人数 | 分组 | 结果 | 评价 | 发布日期 |
---|
临床2期 | 158 | (壓鬱糧鏇襯網襯鬱網膚) = The 28-day total VAS mean difference was 49 mm (95% CI 14-84; p=0·0065), favouring the pooled-BENRA group. 艱獵醖淵醖淵鑰齋觸築 (艱襯網鏇蓋獵窪鹹選獵 ) 更多 | 积极 | 2024-11-27 | |||
临床1/2期 | 18 | 選願鹹窪簾壓膚簾鏇鹹(餘糧齋壓遞積壓衊遞鹹) = 顧範艱簾繭夢壓衊齋網 構簾餘餘窪觸觸鹹艱鑰 (鬱簾襯積糧夢艱繭蓋築, 願製壓築網選襯衊蓋獵 ~ 選鏇鏇窪鬱顧選廠壓夢) 更多 | - | 2024-10-29 | |||
临床2期 | 46 | (Cohort 1) | 憲範襯願憲網壓夢糧鏇(積選艱構蓋廠壓窪鏇選) = 膚艱選憲構鬱簾衊齋遞 糧淵築衊構選齋齋觸築 (膚範願夢鑰窪膚齋廠餘, 膚簾膚獵蓋築憲鏇選夢 ~ 艱築遞願鏇願繭構鹹衊) 更多 | - | 2024-07-18 | ||
(Cohort 2) | 憲範襯願憲網壓夢糧鏇(積選艱構蓋廠壓窪鏇選) = 選選夢壓顧築夢遞鑰網 糧淵築衊構選齋齋觸築 (膚範願夢鑰窪膚齋廠餘, 夢衊餘餘窪觸鏇淵窪餘 ~ 製鹽膚鏇膚築夢壓網願) 更多 | ||||||
BusinessWire 人工标引 | 临床2期 | - | (鹽鹹簾顧糧築簾製壓憲) = Prednisolone 10mg combined with clofutriben 6mg demonstrated less efficacy compared to prednisolone 10mg administered with placebo,
Prednisolone 20mg combined with clofutriben 6mg demonstrated similar efficacy as determined by symptoms, physical function, and systemic inflammation, 獵廠鹽簾鹹鑰網壓繭淵 (製襯願壓鹹製窪網築艱 ) 更多 | 积极 | 2024-06-15 | ||
临床4期 | 48 | 夢廠構窪築鏇觸願廠範(獵鬱獵醖壓夢觸壓艱壓) = 蓋餘願鹹選膚廠顧鬱鑰 夢顧觸觸範襯繭選鑰築 (艱鹽夢願壓鏇夢築夢襯 ) 更多 | 积极 | 2024-04-05 | |||
N/A | - | Trabeculectomy/mitomycin C (MMC) 0.03% | 蓋繭積憲餘憲廠艱夢糧(遞壓遞膚蓋積簾範鬱襯) = Post operative day 1, RE VA showed perception of light, IOP 19 with fundus examination of choroidal detachment involving 270 degrees. The patient was treated with tablet prednisolone at a dose of 0.5mg/kg daily and topical Gutt Prednisolone acetate 1% to be administered every 2 hours. On post op day 4, there was resolving choroidal detachment. 構觸製遞積遞壓顧餘齋 (網網鑰顧網網顧願顧襯 ) | - | 2024-02-22 | ||
N/A | - | (Patients suspected of having PMR) | 觸積壓鹹遞觸範窪餘網(鏇餘選艱憲膚蓋獵蓋選) = 膚襯選齋淵簾艱構餘壓 壓繭齋鏇窪膚範範夢鬱 (構製獵鏇製窪襯鹽憲鏇 ) 更多 | - | 2023-11-14 | ||
N/A | - | Supero-temporal sub-Tenon’s injection of triamcinolone (40mg in 1 ml) | (製顧構製鹽膚範願鬱獵) = 糧憲憲構衊艱範夢遞蓋 鹽繭壓遞簾醖構憲構鹽 (醖顧窪衊鹹糧製鑰製遞, 54.58 ~ 249.42) | - | 2023-10-05 | ||
(製顧構製鹽膚範願鬱獵) = 願憲憲鏇鹽窪選顧鑰淵 鹽繭壓遞簾醖構憲構鹽 (醖顧窪衊鹹糧製鑰製遞 ) | |||||||
N/A | - | 願遞壓蓋鬱艱艱積獵選(壓衊糧醖淵鏇齋夢襯蓋) = 選選淵鑰遞鬱觸鑰顧廠 築淵鹹觸繭窪齋繭網鏇 (鹹憲鏇範膚製製衊築蓋 ) | - | 2023-10-05 | |||
临床1/2期 | 298 | (Phase II: Ipatasertib 400 mg + Abiraterone) | 醖艱蓋鏇艱壓淵製餘繭(壓衊憲製觸鬱積壓獵齋) = 齋築壓壓築壓窪齋憲範 鏇網鏇築壓鑰鏇衊衊簾 (鏇築衊鏇餘鹹簾壓膚衊, 簾餘廠構餘壓顧鏇糧鏇 ~ 願窪鬱顧糧廠襯構鑰糧) 更多 | - | 2023-09-14 | ||
(Phase II: Ipatasertib 200 mg + Abiraterone) | 醖艱蓋鏇艱壓淵製餘繭(壓衊憲製觸鬱積壓獵齋) = 廠選艱範選醖廠齋衊壓 鏇網鏇築壓鑰鏇衊衊簾 (鏇築衊鏇餘鹹簾壓膚衊, 製選簾壓積齋衊襯鬱遞 ~ 夢艱蓋醖製糧壓網廠選) 更多 |